Press Releases

Date	Title and Summary	Additional Formats
Toggle SummaryApr 7, 2015	Agile Therapeutics to Present at the 14th Annual Needham Healthcare Conference Presentation Scheduled on Wednesday, April 15, 2015 at 4:20 PM Eastern Time...	Agile Therapeutics to Present at the 14th Annual Needham Healthcare Conference 14.8 KB
Toggle SummaryMar 26, 2015	Agile Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results Begins 2015 in a Stronger Financial Position...	Agile Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results 26.8 KB
Toggle SummaryMar 2, 2015	Agile Therapeutics to Present at the 27th Annual ROTH Conference Presentation Scheduled on Monday, March 9th, 2015 at 4:30 PM Pacific Time...	Agile Therapeutics to Present at the 27th Annual ROTH Conference 14.7 KB
Toggle SummaryFeb 24, 2015	Agile Therapeutics Secures Debt Facility From Hercules Technology Growth Capital of Up to $25.0 Million and Provides Update on Status of Clinical Trial PRINCETON, N.J. , Feb. 24, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has entered into a loan and security...	Agile Therapeutics Secures Debt Facility From Hercules Technology Growth Capital of Up to $25.0 Million and Provides Update on Status of Clinical Trial 21.1 KB
Toggle SummaryFeb 12, 2015	Agile Therapeutics to Present at the 2015 RBC Capital Markets' Global Healthcare Conference Presentation Scheduled on Wednesday, February 25th, 2015 at 11:00 AM ET...	Agile Therapeutics to Present at the 2015 RBC Capital Markets' Global Healthcare Conference 15.3 KB
Toggle SummaryJan 20, 2015	Agile Therapeutics Announces $20 Million Private Placement and Provides Clinical Trial Update PRINCETON, New Jersey , Jan. 20, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has entered into a definitive...	Agile Therapeutics Announces $20 Million Private Placement and Provides Clinical Trial Update 19.4 KB
Toggle SummaryJan 6, 2015	Agile Therapeutics to Present at Noble Financial Capital Markets' Eleventh Annual Equity Conference Presentation Scheduled on Tuesday, January 20th, 2015 at 3:00 PM ET...	Agile Therapeutics to Present at Noble Financial Capital Markets' Eleventh Annual Equity Conference 17.3 KB
Toggle SummaryDec 22, 2014	Agile Therapeutics to Present at the 33rd Annual J.P. Morgan Healthcare Conference Presentation Scheduled on Thursday, January 15th, 2015 at 9:30 AM Pacific Time...	Agile Therapeutics to Present at the 33rd Annual J.P. Morgan Healthcare Conference 15.3 KB
Toggle SummaryDec 1, 2014	Agile Therapeutics Announces Publication of Data on Low-Dose Investigational Contraceptive Patch Data Demonstrate Skin Adhesion and Tolerability of Twirla(R) in a Large Population of Women Using the Patch for Up to 1 Year...	Agile Therapeutics Announces Publication of Data on Low-Dose Investigational Contraceptive Patch 16.6 KB
Toggle SummaryNov 18, 2014	Agile Therapeutics Appoints John Hubbard, Ph.D., FCP to Its Board of Directors PRINCETON, N.J., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced that John Hubbard, Ph.D., FCP has been appointed to the Company's Board of Directors, effective November 18, 2014. Dr. Hubbard will serve on Agile's Nominating and Corporate Governance...	Agile Therapeutics Appoints John Hubbard, Ph.D., FCP to Its Board of Directors 15.7 KB